All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Avivagen, Inc. revenue reports

Avivagen, Inc. financial reports, Avivagen, Inc. annual revenue in 2024. When does Avivagen, Inc. report revenue?
Add to widgets
Added to widgets

Avivagen, Inc. total revenue, net income and dynamics of changes in US dollar today

Net revenue of Avivagen, Inc. on 30/04/2019 amounted to 303 984 $. The dynamics of Avivagen, Inc. net revenue has changed by -18 141 $ over the last period. The dynamics of Avivagen, Inc. net income fell by -151 122 $. The assessment of the dynamics of Avivagen, Inc. net income was made in comparison with the previous report. The financial report chart shows the values from 31/07/2018 to 30/04/2019. The financial report on the chart of Avivagen, Inc. allows you to clearly see the dynamics of fixed assets. The value of the "total revenue of Avivagen, Inc." on the chart is marked in yellow.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/04/2019 303 984 $ - -1 292 919 $ -
31/01/2019 322 125 $ - -1 141 797 $ -
31/10/2018 346 284 $ - -1 541 137 $ -
31/07/2018 364 213 $ - -1 031 779 $ -
Show:
to

Avivagen, Inc. financial report charts

Dates of Avivagen, Inc. finance reports: 31/07/2018, 31/01/2019, 30/04/2019. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Avivagen, Inc. is 30/04/2019. Gross profit Avivagen, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Avivagen, Inc. is 154 279 $

Avivagen, Inc. quarterly report dates

Cost of revenue Avivagen, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Avivagen, Inc. is 149 705 $ Total revenue Avivagen, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Avivagen, Inc. is 303 984 $ Operating income Avivagen, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Avivagen, Inc. is -1 059 964 $

Net income Avivagen, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Avivagen, Inc. is -1 292 919 $ Current assets Avivagen, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Avivagen, Inc. is 3 732 433 $ Total assets Avivagen, Inc. refers to the total amount of assets owned by a person or entity. Total assets Avivagen, Inc. is 3 797 114 $

  30/04/2019 31/01/2019 31/10/2018 31/07/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
154 279 $ 183 162 $ 203 363 $ 225 775 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
149 705 $ 138 963 $ 142 921 $ 138 438 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
303 984 $ 322 125 $ 346 284 $ 364 213 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-1 059 964 $ -1 028 243 $ -1 079 416 $ -937 616 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-1 292 919 $ -1 141 797 $ -1 541 137 $ -1 031 779 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
285 858 $ 158 289 $ 6 449 $ 182 828 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
1 363 948 $ 1 350 368 $ 1 425 700 $ 1 301 829 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
3 732 433 $ 2 052 760 $ 3 042 231 $ 3 560 497 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
3 797 114 $ 2 118 600 $ 3 109 230 $ 3 628 655 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
3 225 201 $ 1 436 891 $ 2 207 393 $ 3 003 099 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
1 272 601 $ 2 814 532 $ 1 009 987 $ 590 693 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
4 931 973 $ 3 083 798 $ 3 015 451 $ 2 455 052 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
129.89 % 145.56 % 96.98 % 67.66 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-1 134 859 $ -965 198 $ 93 779 $ 1 173 603 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-1 138 548 $ -735 875 $ -766 044 $ -932 798 $

Last revenue report of Avivagen, Inc. was 30/04/2019. According to last financial report total revenue in Avivagen, Inc. was 303 984 US dollar and changed by 0% since last year. Net income in Avivagen, Inc. was -1 292 919 $ in last quartal, net income changes to 0%.

Current cash Avivagen, Inc. - the sum of all of the cash a company has on the date of report. Current cash Avivagen, Inc. is 3 225 201 $ Current debt Avivagen, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Avivagen, Inc. is 1 272 601 $ Total debt Avivagen, Inc. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Avivagen, Inc. is 4 931 973 $

Avivagen, Inc. stocks data

Avivagen, Inc. financials